Midwest Antiviral Drug Discovery (AViDD) Center at UofM
@midwestavidd.bsky.social
Our mission at the Midwest Antiviral Drug Discovery (AViDD) Center is to quickly develop the next generation of antiviral drugs for pandemic-level viruses, including SARS-CoV-2, Ebola, Lassa and Zika.
Find the impact of NIH dollars in your state www.unitedformedicalresearch.org/nih-in-your-...
February 10, 2025 at 6:19 PM
Find the impact of NIH dollars in your state www.unitedformedicalresearch.org/nih-in-your-...
A new study by the Midwest AViDD Center reveals that Sudan ebolavirus glycoprotein binds to the human NPC1 receptor approximately 9 times more strongly than Ebola virus glycoprotein. midwestavidd.umn.edu/new-study-re...
New Study Reveals How Sudan Virus Binds to Human Cells | Midwest Antiviral Drug Discovery (AViDD) Center
midwestavidd.umn.edu
February 4, 2025 at 6:04 PM
A new study by the Midwest AViDD Center reveals that Sudan ebolavirus glycoprotein binds to the human NPC1 receptor approximately 9 times more strongly than Ebola virus glycoprotein. midwestavidd.umn.edu/new-study-re...